Armistice Capital »

Aytu Biopharma shares owned by Armistice Capital

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $736k 252k 2.92

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Aytu Biopharma

Nantahala Capital Management
Stonepine Capital Management
Armistice Capital
Renaissance Technologies
Geode Capital Management
Vanguard Group
BlackRock
BlackRock
Dimensional Fund Advisors
Acadian Asset Management
Northern Trust
Tower Research Capital
Morgan Stanley
Jpmorgan Chase & Co
Advisor Group Holdings

View all funds holding Aytu Biopharma